A pharmaceutical company is developing a new antibacterial medication that is safe for use in humans. Which two of the following would NOT be good targets for the medication? Glycolytic pathway enzyme activity
80S
ribosome functioning 705 ribosome Bacterial DNA gyrase functioning activity Lipopolysaccharide synthesis
?
Peptidoglycan synthesis Reset